Caifeng Fu
Impact in
- Clinical Biochemistry top 0.05%
- Advanced Glycation End Products research
-
- Natural Antidiabetic Agents Studies
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Advanced Glycation End Products research 5
- Virology 3
- HIV Research and Treatment 3
- Co-authors
- Ann Marie Schmidt (5 shared papers)David M. Stern (4 shared papers)Thomas Kislinger (4 shared papers)Marion A. Hofmann (3 shared papers)Wu Qu (3 shared papers)Akihiko Taguchi (2 shared papers)Monika Pischetsrieder (2 shared papers)Nozomu Tanji (2 shared papers)
- Journals
- Nature (1 paper)Cell (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)Clinical Pharmacology Advances and Applications (1 paper)Journal of the American Society of Nephrology (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Caifeng Fu
13 papers receiving 4.4k citations
Caifeng Fu's Hit Papers
Peers
Comparison fields: 5 of 105
- Clinical Biochemistry 3.0k
- Endocrinology, Diabetes and Metabolism 857
- Nephrology 333
- Immunology 774
- Neurology 267
Countries citing papers authored by Caifeng Fu
This map shows the geographic impact of Caifeng Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caifeng Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caifeng Fu more than expected).
Fields of papers citing papers by Caifeng Fu
This network shows the impact of papers produced by Caifeng Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caifeng Fu. The network helps show where Caifeng Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Caifeng Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | RAGE Mediates a Novel Proinflammatory Axis Hit paper breakdown → | 1999 | 1662 |
| 2 | Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases Hit paper breakdown → | 2000 | 1091 |
| 3 | N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression Hit paper breakdown → | 1999 | 801 |
| 4 | 2002 | 481 | |
| 5 | 2000 | 417 | |
| 6 | 2010 | 22 | |
| 7 | 2019 | 17 | |
| 8 | 2020 | 12 | |
| 9 | 2018 | 8 | |
| 10 | 2019 | 7 | |
| 11 | 2017 | 4 | |
| 12 | 2020 | 3 | |
| 13 | 2008 | 3 |
About Caifeng Fu
Caifeng Fu is a scholar working on Clinical Biochemistry, Virology, Infectious Diseases, Gastroenterology and Pediatrics, Perinatology and Child Health, having authored 13 papers that have together received 4.5k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (5 papers), HIV/AIDS drug development and treatment (5 papers), HIV Research and Treatment (3 papers), Biochemical and Molecular Research (2 papers), S100 Proteins and Annexins (2 papers), Gastroesophageal reflux and treatments (2 papers), HIV/AIDS Research and Interventions (1 paper) and Chronic Kidney Disease and Diabetes (1 paper). The work is most often cited by research in Clinical Biochemistry (3.0k citations), Endocrinology, Diabetes and Metabolism (857 citations), Nephrology (333 citations), Immunology (774 citations) and Neurology (267 citations). Caifeng Fu has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Ann Marie Schmidt, David M. Stern, Thomas Kislinger, Marion A. Hofmann, Wu Qu, Akihiko Taguchi, Monika Pischetsrieder, Akihiko Taguchi, Nozomu Tanji and John McClary. Their work appears in journals such as Nature, Cell, Antimicrobial Agents and Chemotherapy, Clinical Pharmacology Advances and Applications and Journal of the American Society of Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.